Associations of adipokines & insulin resistance with sex steroids in patients with breast cancer

Indian Journal of Medical Research

Volumn 135, Issue 4, 2012, Pages 500-505

  Al Awadhi, Shafka A ^a   Al Khaldi, Rasha M ^a   Al Rammah, Tahani ^a   Kapila, Kusum ^a   Mojiminiyi, Olusegun A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Adipokines; Breast cancer; Obesity; Sex steriods

Indexed keywords

ADIPONECTIN; ESTRADIOL; FOLLITROPIN; LEPTIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; WAIST CIRCUMFERENCE;

ADIPOKINES; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GONADAL STEROID HORMONES; HUMANS; INSULIN RESISTANCE; LEPTIN;

EID: 84861945114     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Key T, Allen N, Verkasalo P, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001; 60: 81-89.
2. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5: 153-165.
3. Rajala M, Scherer P. The adipocyte - At the crossroads of homeostasis, infammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773.
4. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004; 89: 1102-1107.
5. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
6. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, et al. Is leptin a mediator adverse prognostic effects of obesity in breast cancer? J Clin Oncol 2005; 23: 6037-6042.
7. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
8. Karliner LS, Kerlikowske K. Ethnic disparities in breast cancer. Women Health 2007; 3: 679-88.
9. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502.
10. Mojiminiyi O, Abdella N, Al-Arouj M, Ben Nakhi A. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes. Int J Obesity 2007; 31: 213-220.
11. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
12. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996; 7: 605-625.
13. Papa V, Belfore A. Insulin receptors in breast cancer: Biological and clinical role. J Endocrinol Invest 1996; 19: 324-333.
14. Hankinson SE, Schernhammer ES. Insulin-like growth factor and breast cancer risk: evidence from observational studies. Breast Dis 2003; 17: 27-40.
15. Kasid D, Lipman L. Regulation of growth factors by estrogen through the estrogen ereceptor. J Steroid Biochem 1987; 27: 465-470.
16. Russo J, Russo IH. Genotoxicity of steroid estrogens. Trends Endocrinol Metab 2004; 15: 211-214.
17. Dorgan J, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5: 533-539.
18. Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005; 113: 499-502.
19. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Splegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-1299.
20. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of osteoporotic fractures research group. Ann Intern Med 1999; 130: 270-277.
21. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. Tissue levels of adiponectin in breast cancer patients. Med Oncol 2007; 24: 361-366.
22. Jamieson NB, Brown DJ, Michael WA, McMillan DC. Adiponectin and the systemic infammatory response in weight-losing patients with non small cell lung cancer. Cytokine 2004; 27: 90-92.
23. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-426.
24. Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, et al. Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 2004; 86: 191-196.
25. Artwohl M, Roden M, Hölzenbein T, Freudenthaler A, Waldhäusl W, Baumgartner-Parzer SM. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 2002; 26: 577-580.